Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
The Best Stocks to Invest $1,000 in Right Now
High energy costs. High stock valuations. High volatility. It’s enough to make an investor feel low.
The good news is that there are still plenty of great stocks to buy despite the market uncertainty. I’m talking about investing in companies with competitive advantages, financial strength, relatively low risk profiles, and strong growth prospects. Here are my picks for three of the best stocks to invest $1,000 in right now.
Image source: Getty Images.
I firmly believe that Alphabet (GOOG +0.06%) (GOOGL +0.35%) is the best all-around artificial intelligence (AI) stock on the market. Pick an area within the broader AI arena – large language models (LLMs), AI chips, self-driving cars, robotics, etc. Alphabet is a leader in practically all of them.
Alphabet’s Google Cloud has become an overwhelming success. Its revenue skyrocketed 48% year over year in the fourth quarter of 2025, the fastest growth among the top three cloud service providers. Google Cloud is also highly profitable now, generating around 15% of Alphabet’s total operating income in Q4.
Expand
NASDAQ: GOOGL
Alphabet
Today’s Change
(0.35%) $1.06
Current Price
$302.06
Key Data Points
Market Cap
$3.7T
Day’s Range
$300.93 - $305.98
52wk Range
$140.53 - $349.00
Volume
12K
Avg Vol
33M
Gross Margin
59.68%
Dividend Yield
0.28%
Of course, Alphabet still makes most of its money from advertising on Google Search, YouTube, and other platforms. Thanks in part to AI, the company’s ad revenue continues to grow robustly. Integration of the Gemini AI model with Google Search in the AI Overviews and AI Mode functions has even boosted search traffic.
Alphabet is also one of the most attractively valued “Magnificent Seven” stocks, in my opinion. Its shares trade at less than 23 times projected 2027 earnings. This AI giant is a textbook example of a stock that offers growth at a reasonable price.
If there’s any stock that’s right for the moment, it’s Chevron (CVX +1.73%). Iran’s interference with shipping in the Strait of Hormuz has caused oil prices to skyrocket. So has Chevron’s share price.
Expand
NYSE: CVX
Chevron
Today’s Change
(1.73%) $3.48
Current Price
$205.21
Key Data Points
Market Cap
$409B
Day’s Range
$197.37 - $205.36
52wk Range
$132.04 - $205.36
Volume
8.1K
Avg Vol
12M
Gross Margin
14.66%
Dividend Yield
3.37%
However, Chevron isn’t a great pick only because of the current geopolitical crisis. It ranks as the world’s third-largest energy company by market cap. Chevron’s scale and financial strength make it a reliable stock to own even when oil prices fluctuate.
Management targets double-digit adjusted free cash flow and earnings-per-share growth. Chevron is the largest player in the natural gas market, with strong growth prospects over the next few years. The company’s acquisition of Hess gives it a significant opportunity to increase production in Guyana. Chevron is also uniquely positioned in Venezuela as the only major U.S. oil company to maintain a presence there over the years.
I can’t talk about Chevron without mentioning its dividend. The company has increased its dividend for an impressive 39 consecutive years. Its dividend yield currently tops 3.5%. What if oil prices fall? No problem. Chevron can cover its dividend payments and all capital expenditures, even if oil prices sink below $50 per barrel.
Investors often view big pharma stocks as safe ports in a storm. And there’s no bigger pharma stock than Eli Lilly (LLY +0.42%).
Lilly’s tremendous growth in recent years has been driven primarily by its GLP-1 drugs, Mounjaro and Zepbound, which treat Type 2 diabetes and obesity, respectively. These two drugs together generated a whopping $36.5 billion in sales last year. But they still have plenty of growth opportunities ahead.
Expand
NYSE: LLY
Eli Lilly
Today’s Change
(0.42%) $3.81
Current Price
$910.51
Key Data Points
Market Cap
$860B
Day’s Range
$907.85 - $926.30
52wk Range
$623.78 - $1133.95
Volume
156K
Avg Vol
3.1M
Gross Margin
83.04%
Dividend Yield
0.68%
However, Lilly’s fortunes don’t hinge entirely on the diabetes and obesity markets. The company’s breast cancer drug, Verzenio, is a megablockbuster. Lilly is also a major player in treating autoimmune diseases, Alzheimer’s disease, and other indications.
The main knock against Lilly is its valuation. I think, though, that the drugmaker’s growth potential justifies a premium price. While Lilly’s shares trade at nearly 27 times projected 2026 earnings, the stock’s forward earnings multiple based on 2030 earnings projections is only around 15x.